MYOZYME
MYOZYME
Approved
DIN Number
02284863
Drug Class
Human
Market Date
Dec 6, 2006
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02284863
AIG Number0151663001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB07 ALGLUCOSIDASE ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALGLUCOSIDASE ALFAActive
Strength: 50 MG / VIAL
Monograph: ALGLUCOSIDASE ALFA